Cargando…
Case–Control Study of Long COVID, Sapporo, Japan
We conducted a cross-sectional survey among SARS-CoV-2–positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,694 case-patients and 3,672 controls. We calculated symptom prevalence for case-patients at 2–3, 4–6,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124665/ https://www.ncbi.nlm.nih.gov/pubmed/37044126 http://dx.doi.org/10.3201/eid2905.221349 |
_version_ | 1785029885548298240 |
---|---|
author | Asakura, Toshiaki Kimura, Takashi Kurotori, Isaku Kenichi, Katabami Hori, Miyuki Hosogawa, Mariko Saijo, Masayuki Nakanishi, Kaori Iso, Hiroyasu Tamakoshi, Akiko |
author_facet | Asakura, Toshiaki Kimura, Takashi Kurotori, Isaku Kenichi, Katabami Hori, Miyuki Hosogawa, Mariko Saijo, Masayuki Nakanishi, Kaori Iso, Hiroyasu Tamakoshi, Akiko |
author_sort | Asakura, Toshiaki |
collection | PubMed |
description | We conducted a cross-sectional survey among SARS-CoV-2–positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,694 case-patients and 3,672 controls. We calculated symptom prevalence for case-patients at 2–3, 4–6, 7–9, 10–12, and 13–18 months after illness onset. We used logistic regression, adjusted for age and sex, to estimate the odds ratio (OR) for each symptom and control reference. We calculated symptom prevalence by stratifying for disease severity, age, and sex. At 4–18 months from illness onset, ORs for anosmia, ageusia, dyspnea, alopecia, and brain fog were consistently >1, whereas ORs for common cold–like, gastrointestinal, and dermatologic symptoms were <1. Time trend ORs increased for diminished ability to concentrate, brain fog, sleep disturbance, eye symptoms, and tinnitus. Clinicians should focus on systemic, respiratory, and neuropsychiatric symptoms among long COVID patients. |
format | Online Article Text |
id | pubmed-10124665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-101246652023-05-01 Case–Control Study of Long COVID, Sapporo, Japan Asakura, Toshiaki Kimura, Takashi Kurotori, Isaku Kenichi, Katabami Hori, Miyuki Hosogawa, Mariko Saijo, Masayuki Nakanishi, Kaori Iso, Hiroyasu Tamakoshi, Akiko Emerg Infect Dis Research We conducted a cross-sectional survey among SARS-CoV-2–positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,694 case-patients and 3,672 controls. We calculated symptom prevalence for case-patients at 2–3, 4–6, 7–9, 10–12, and 13–18 months after illness onset. We used logistic regression, adjusted for age and sex, to estimate the odds ratio (OR) for each symptom and control reference. We calculated symptom prevalence by stratifying for disease severity, age, and sex. At 4–18 months from illness onset, ORs for anosmia, ageusia, dyspnea, alopecia, and brain fog were consistently >1, whereas ORs for common cold–like, gastrointestinal, and dermatologic symptoms were <1. Time trend ORs increased for diminished ability to concentrate, brain fog, sleep disturbance, eye symptoms, and tinnitus. Clinicians should focus on systemic, respiratory, and neuropsychiatric symptoms among long COVID patients. Centers for Disease Control and Prevention 2023-05 /pmc/articles/PMC10124665/ /pubmed/37044126 http://dx.doi.org/10.3201/eid2905.221349 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Asakura, Toshiaki Kimura, Takashi Kurotori, Isaku Kenichi, Katabami Hori, Miyuki Hosogawa, Mariko Saijo, Masayuki Nakanishi, Kaori Iso, Hiroyasu Tamakoshi, Akiko Case–Control Study of Long COVID, Sapporo, Japan |
title | Case–Control Study of Long COVID, Sapporo, Japan |
title_full | Case–Control Study of Long COVID, Sapporo, Japan |
title_fullStr | Case–Control Study of Long COVID, Sapporo, Japan |
title_full_unstemmed | Case–Control Study of Long COVID, Sapporo, Japan |
title_short | Case–Control Study of Long COVID, Sapporo, Japan |
title_sort | case–control study of long covid, sapporo, japan |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124665/ https://www.ncbi.nlm.nih.gov/pubmed/37044126 http://dx.doi.org/10.3201/eid2905.221349 |
work_keys_str_mv | AT asakuratoshiaki casecontrolstudyoflongcovidsapporojapan AT kimuratakashi casecontrolstudyoflongcovidsapporojapan AT kurotoriisaku casecontrolstudyoflongcovidsapporojapan AT kenichikatabami casecontrolstudyoflongcovidsapporojapan AT horimiyuki casecontrolstudyoflongcovidsapporojapan AT hosogawamariko casecontrolstudyoflongcovidsapporojapan AT saijomasayuki casecontrolstudyoflongcovidsapporojapan AT nakanishikaori casecontrolstudyoflongcovidsapporojapan AT isohiroyasu casecontrolstudyoflongcovidsapporojapan AT tamakoshiakiko casecontrolstudyoflongcovidsapporojapan |